Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling unwell on Mounjaro is one of the most common reasons people contact their prescriber in the first few weeks of treatment. Most side effects are gastrointestinal, well-documented in clinical trial data, and tend to ease as the body adjusts — but some symptoms warrant urgent medical attention, and knowing which is which matters. Mounjaro (tirzepatide) is a prescription-only medicine, and any persistent or concerning symptoms should be reviewed by a clinician rather than managed alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, which followed thousands of adults on tirzepatide over 72 weeks and is the cornerstone of Mounjaro's evidence base, recorded gastrointestinal side effects as the most frequently reported adverse events across all doses. Nausea was the most common, followed by diarrhoea, vomiting, constipation, indigestion and burping. These effects were most pronounced in the early weeks and after each dose increase, then generally settled.
The biological reason is straightforward. Tirzepatide activates both GIP and GLP-1 receptors, pathways that also govern how quickly food moves through the stomach. Slowing gastric emptying is what makes you feel full sooner and eat less, but it is also what produces nausea and bloating in people who are not yet used to the drug. It is not a sign the medicine is harming you; it is the mechanism working.
Fatigue, headaches and dizziness also featured in trial data, particularly in the first fortnight. These are worth noting but are generally self-limiting. If you want the full list of effects recorded in the trial programme, the NHS tirzepatide medicines page sets them out clearly alongside guidance on severity.
For a broader look at what tirzepatide involves before or during treatment, including the commercial name tirzepatide is sold under, the tirzepatide overview on this site covers the clinical picture in more depth.
Not everything that feels bad is routine adjustment. The MHRA issued a Drug Safety Update in January 2026 specifically flagging acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines including tirzepatide. The symptom pattern to watch for: severe stomach pain that comes on suddenly, persists without easing, and may spread through to the back, sometimes with vomiting. That combination is an instruction to stop the injection and call 111 or go to A&E, not to wait and see whether it settles by morning.
Other symptoms that should not be dismissed: signs of a serious allergic reaction (swelling of the face, throat or tongue; difficulty breathing; sudden rash), severe dehydration from repeated vomiting or diarrhoea, and any episode of low mood or thoughts of self-harm. These are rare, but they are documented, and the Yellow Card scheme at yellowcard.mhra.gov.uk exists precisely so that rare signals get reported and acted on.
Gallbladder problems (right-sided or mid-upper abdominal pain, sometimes with fever or jaundice) are also listed in the Mounjaro safety profile. If something in your abdomen feels acutely wrong, get it checked. Your prescriber would far rather hear from you than have you sit through a weekend of worsening pain.
For specific symptom patterns some people notice on Mounjaro, this page on generally feeling ill on Mounjaro covers the most common complaints in more detail.
For the ordinary nausea, bloating and queasiness that most people navigate early on, the adjustments that tend to help are modest and practical. Eating smaller portions more slowly gives a stomach that is already emptying sluggishly less to deal with. Fatty, spicy or very rich food amplifies nausea and is worth avoiding on injection days and the day after. Staying well hydrated matters particularly if you have loose stools, small, frequent sips rather than large glasses.
Some people find the evening a better time for their injection than the morning, simply because sleeping through the first few hours of nausea is more comfortable than sitting at a desk with it. That said, injection timing is a conversation for your prescriber, not a self-adjustment. The same applies to dose timing: if you feel the nausea has not settled before the next four-week increase is due, your prescriber can hold the dose where it is. Titration schedules exist to be adapted, not rigidly followed if the side-effect burden is high.
A note on one thing that catches people out: the Mounjaro pen needs to come out of the fridge roughly 30 minutes before injection. Cold injections can sting more and may contribute to injection-site discomfort, one of the subtler sources of feeling off after a dose. It takes seconds to plan, particularly if you have a regular morning routine, leaving it out while you make tea is enough.
If you are specifically noticing cold sensitivity or temperature changes on treatment, this page on feeling cold on Mounjaro looks at what is known about that experience. People also report unusual warmth or flushing, which the Mounjaro and feeling hot page addresses separately.
A useful rule of thumb: side effects that are mild and improving are usually fine to manage with the adjustments above. Side effects that are moderate-to-severe, not improving after two weeks at a given dose, or affecting your ability to eat, drink or function day-to-day are a reason to contact your prescriber promptly.
Muscle weakness and unusual fatigue that feel different from ordinary tiredness are also worth raising, particularly if they appear after a dose increase. Feeling weak on Mounjaro has a dedicated page for that specific concern.
The NHS England guidance on weight management injections reinforces that GLP-1 treatment is intended to be clinically supervised throughout, not just at the start. That supervision exists so that side effects are caught and managed, doses are adjusted appropriately, and the treatment actually works for you over time rather than being abandoned because of manageable discomfort.
If you are being treated through nume, our prescribers are available seven days a week through aftercare. A message through the contact page reaches the clinical team directly, and if a symptom genuinely worries you, that is exactly the kind of thing they are there for. Feeling unwell does not have to mean stopping treatment; it often just means adjusting it. Speak to our prescribers if you are unsure where your symptoms sit.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.